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In the fall of 2001, the editor-in-chief of the Netherlands 
Journal of Medicine at that time, Professor Andy 
Hoepelman, phoned me and asked whether we, at the 
Department of Medicine of the Radboud University 
Nijmegen Medical Centre, would be willing to take over 
the editorial board. After a short discussion with my close 
colleagues Theo Thien, Anton Stalenhoef and Paul Smits, 
we decided to accept this challenge. The impact factor of 
the Netherlands Journal of Medicine had slowly risen over 
the past years up to 0.8,1 so there was certainly a challenge 
to try and increase it further. Being within the package of 
Elsevier could probably help.
While preparing ourselves for the job, the members of the 
board of the Netherlands Association for Internal Medicine 
(NIV), the owner of the Journal, decided they wanted to 
make a change regarding the publisher. In fact, Elsevier 
charged the NIV a large sum of money for the journal 
(some 1 100,000 a year) and probably because of this easy 
income, did not undertake any efforts to make the Journal 
more attractive, and did not even try to raise money from 
advertisements.
One solution would have been to merge with one of the 
other journals on internal medicine in Europe, but this 
turned out to be very complicated.
Then, Loek van Zuiden, a medical publisher in the 
Netherlands who was already publishing a newsletter 
and consensus reports for the NIV, made an attractive 
offer, which the board of the NIV accepted. We exchanged 
ideas with him about the Journal. He felt he could do a 
better job than Elsevier: publish fast, change the format to 
A4, get rid of the glossy pages (which are hard to read at 
lamplight), avoid the waste of paper by not starting a new 
article a little above the middle of a new page, make a more 
attractive cover (in better colours) and change the logo of 
the Journal.
As an amateur artist, I contributed in at least three ways 
to the appearance of the Journal. In the first place I made 
a design for the logo. To give it a more international 
appearance, I wanted to give the impression that we were 
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dealing with the Journal of Medicine and in a casual way I 
inserted Netherlands.
Secondly, inspired by JAMA and Clinical Infectious 
Diseases, I felt that art on the cover would make the 
Journal attractive. As an amateur graphic artist (see 
cover), I proposed to put contemporary Dutch graphic art 
on the cover. This was arranged with Caroline Koenders, 
a prominent Dutch graphic artist, through her art gallery 
Unita in Beek Ubbergen. For five years, Caroline managed 
to provide the readership of the Journal with a kaleidoscopic 
view of contemporary graphic art on the cover. Three 
expositions of these covers were organised over the past 
years and the editors also used the originals as yearly 
awards for the best papers published in the journal.
My third artistic input in the Journal was and still is the 
cartoon that appears in each issue. I had already been 
drawing the cartoons for Mediator since its early days, and 
felt it should be possible to draw a cartoon for each issue 
of the Journal. It should be realised that it is slightly more 
difficult to design cartoons for a clinical journal, as it can 
be considered unethical to make jokes about sick people. 
I think, however, I have managed to stay away from that 
problem.
That I have, so far, not yet dealt with the medical content 
of the Journal does not mean that I do not consider that of 
importance. In the first editorial from Nijmegen,2 we stated 
that we wanted to provide a clinical and scientific forum 
for exposure of the high quality of internal medicine in 
the Netherlands. The risk of a journal with a relatively low 
impact factor is of course that the really good papers are 
not submitted to it and that the editors end up with a pile 
of case reports next to a smaller pile of articles that were 
rejected elsewhere. In fact, there is nothing wrong with 
good case reports, as they can serve as a starting point 
for new research.3,4 For the resident in internal medicine, 
writing a case report is a good exercise in putting a 
message in a scientifically sound fashion on paper, in 
order to teach others about an interesting case. In an era in 
which knowledge coupling has become a matter of seconds 
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to minutes, these lessons can be read all over the world and 
be used for the benefit of patients. So case reports: yes, but 
good ones!
The other problem is perhaps bigger. How to get the good 
original papers and reviews. At the editorial board that I 
chaired, we struggled with this, and here I would like to 
make a couple of remarks. First of all, without good papers 
a journal does not deserve a rising impact factor. Thus, 
we invited and even urged some prominent internists 
and biomedical scientists to provide us with good original 
papers and reviews. Many never came. To try and fill 
this gap we published some of our own good work in the 
Journal. Apart from a positive effect (rapid publication 
and full exposure on the internet, see below), this gave 
rise to two negative effects. The first one was that some 
people said that we had an easy job getting our papers 
published in our house journal. The other problem is 
that the Federation of University Medical Centres (NFU) 
came up with the idea to use the Van Raan analysis for 
benchmarking. There is a lot to say about this method. 
Suffice to say here, the analysis makes use of the average 
impact factor of an author. It is clear that that is not 
good for publications in Dutch journals and for authors 
publishing in such journals.
Another phenomenon that annoyed us as editors was 
the appearance of a series of new Dutch subspeciality 
journals, most of them heavily sponsored by industry and 
probably soliciting paid contributions from prominent 
Dutch doctors. To our mind a waste of effort and money.
Despite our efforts, the impact factor dropped during 
the period that I was chief editor. There are at least three 
explanations for this. The transfer from Elsevier to Van 
Zuiden Communications did not go smoothly. As to 
be expected, Elsevier did not want to help us, but there 
was clear obstruction on their part which damaged the 
visibility of the Journal. Secondly, it took a while before 
the electronic version of the Journal became available. 
The way the Journal can now be reached full text on the 
net (FUTON)5 stands out among the other journals. The 
third explanation was that we were not providing the ISI 
with optimal information. This was improved later with a 
positive effect on the impact factor. 
By the end of 2004, I decided to hand over the chief 
editorship to Anton Stalenhoef.6 Although I would have 
loved to stay on, the job was just incompatible with 
becoming chairman of the Concilium Medicinae Internae 
(the board that governs the internal medicine speciality 
training in the Netherlands) and membership of the board 
of the NIV, and last but not least, becoming vice president 
of the Royal Netherlands Academy of Arts and Sciences 
(KNAW). I must say that I enjoyed the three-year period I 
served as chief editor immensely. With the other members 
of the editorial board, we really changed the Journal and 
took the opportunities to improve it. There is still a lot to do 
to further expand the Journal, and I believe there is a great 
future ahead for The (Netherlands) Journal of Medicine.
r E f E r E N C E s
Hoepelman IM. The Netherlands Journal of Medicine: end of a fruitful 1. 
period and a new start. Neth J Med. 2001;59:267-9.
Van der Meer JWM. Editorial. Neth J Med. 2002;60:3.2. 
Vandenbroucke JP. In defense of case reports and case series. Ann Intern 3. 
Med. 2001;134:330-4.
Van der Meer JWM. Should we do away with case reports? Neth J Med. 4. 
2002;60:161.
Van der Meer JWM, Stalenhoef AFH, Smits P, Thien T. Abstract! Neth J 5. 
Med. 2002;60:418.
Stalenhoef AFH. Changes in the editorial staff of the Journal. Neth J Med. 6. 
2005;63:1.
E r r A T A
The corresponding author of the article ‘Clinical course and prognostic factors of clinical early IgA nephropathy’ by 
P. Shen, L. He and D. Huang, as published in Neth J Med. 2008;66(6):242-7, is L. He instead of P. Shen.
Furthermore the following footnote lacked ‘The article was supported by Shanghai Leading Academic Discipline 
Profject (Project Number: Y0302)’.
